Antitumor antibiotic BMY-41219
US5326754A · kind A · utility
4Cited by
7References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 1993 |
| Grant date | Jul 5, 1994 |
| Priority date | — |
| Expiry date | May 18, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/044
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antitumor antibiotic designated BMY-41219 is produced by fermentation of Saccharothrix aerocolonigenes ATCC 39243. The BMY-41219 antibiotic exhibits antitumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.